शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
DRREDDYBSEDr Reddys Laboratories Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 19 Sept, 2025 · 11:02 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VSD Family Trust & PACs

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹1322.50
prior close
₹1314.20
announcement price
In-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.2%+0.2% vs market
Pharmaceuticals peers, median of 153sector+0.1%-0.2% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty 100 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.3
15m
+0.3
30m
+0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0-0.2+0.2+0.1-0.2
Next day
-1.5-0.6-1.0-0.7-0.8
2d
-1.3-0.8-0.5-0.9-0.4
3d
-1.9-1.3-0.5-1.1-0.7
4d
-3.6-2.0-1.6-2.2-1.4
5d
-5.2-3.0-2.1-4.1-1.1
1w
-7.2-3.0-4.2-4.1-3.1
15d
-4.6-0.8-3.7-3.4-1.1
1m
-2.8+1.4-4.2-3.5+0.7
2m
-5.5+2.1-7.6-6.4+1.0
3m
-3.2+1.6-4.8-8.6+5.4
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoters Satish Reddy Kallam and G V Prasad transferred a combined 17,17,26,540 equity shares (20.57% of the company) to two family trusts on September 17, 2025 via an off-market deal. Satish Reddy Kallam moved 7,56,30,620 shares (9.06%) into VSD Family Trust, while G V Prasad moved 9,60,95,920 shares (11.51%) into GVP Family Trust. The transfer was carried out under a SEBI exemption order dated December 31, 2024. The company stated this is a private family arrangement for succession planning and streamlining of family assets. Total promoter and promoter-group shareholding remains unchanged at 26.64% before and after the transfer.

Likely market impact

This is an internal family restructuring with no change in overall promoter holding, so it is largely neutral for shareholders and should not affect stock price. The shift from individuals to family trusts may bring some clarity on succession but does not alter control or voting power.